Myriad Genetics Inc (NASDAQ:MYGN)

39.52
Delayed Data
As of Jun 19
 -0.65 / -1.62%
Today’s Change
23.28
Today|||52-Week Range
41.57
+15.07%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Capone Mark C
President & Chief Executive Officer
Sale5/30/201890,000$38.00$3.4M+7.60%
Capone Mark C
President & Chief Executive Officer
Buy5/30/201890,000$22.93$2.1M+7.60%
Marsh Richard M
Executive Vice President & General Counsel
Sale1/18/201840,000$38.25$1.5M+4.03%
Marsh Richard M
Executive Vice President & General Counsel
Sale1/22/201837,654$40.25$1.5M-0.90%
Marsh Richard M
Executive Vice President & General Counsel
Sale5/30/201833,139$38.00$1.3M+7.60%
Marsh Richard M
Executive Vice President & General Counsel
Buy1/18/201840,000$30.12$1.2M+4.03%
King Gary A /myriad/
Executive Vice President
Sale1/22/201830,000$39.77$1.2M-0.90%
Langer Dennis H
Director
Sale6/01/201830,000$38.90$1.2M+0.13%
Gilbert Walter A
Director
Sale6/05/201828,811$39.68$1.1M-0.68%
Marsh Richard M
Executive Vice President & General Counsel
Buy1/22/201837,654$30.12$1.1M-0.90%
Page of 9